iCo Therapeutics Inc. (ICO):企業概要、財務及び戦略的SWOT分析

◆英語タイトル:iCo Therapeutics Inc. (ICO) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH57257FSA
◆発行会社(調査会社):GlobalData
◆発行日:2015年1月9日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD300 ⇒換算¥33,900見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD600 ⇒換算¥67,800見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD900 ⇒換算¥101,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary

iCo Therapeutics Inc. (iCo) is a pharmaceutical company. The company develops and commercializes drug candidates for treating ocular and systemic fungal diseases. Its products include iCo-007, iCo-008 and Oral AmpB Delivery System. iCo’s Oral AmpB Delivery System is a proprietary oral formulation of amphotericin B for treatment of systemic fungal infections in immunocompromised patients such as human immunodeficiency virus (HIV)/acquired immune deficiency syndrome (AIDS), cancer, transplant recipients, diabetics and some parasitic infections. The company’s iCo-008 is a human monoclonal antibody targeting eotaxin-1. Its iC0-007 is a new generation antisense candidate used for treatment of diabetic macular edema. iCo is headquartered in Vancouver, British Columbia, Canada.

iCo Therapeutics Inc. Key Recent Developments

Dec 20, 2013: iCo Therapeutics Begins Trading on the OTCQX Marketplace
Dec 12, 2013: iCo Therapeutics Announces Program and Intellectual Property Advancements for Oral Amphotericin B
Dec 05, 2013: iCo Therapeutics To Present At Jefferies Ophthalmic Therapeutic Summit
Nov 27, 2013: iCo Therapeutics Announces Third Quarter 2013 Financial Results
Nov 21, 2013: iCo Therapeutics to Present at the 6th Annual LD MICRO Conference

This comprehensive SWOT profile of iCo Therapeutics Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of iCo Therapeutics Inc. including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

iCo Therapeutics Inc. – Key Information
iCo Therapeutics Inc. – Overview
iCo Therapeutics Inc. – Key Employees
iCo Therapeutics Inc. – Key Employee Biographies
iCo Therapeutics Inc. – Key Operational Heads
iCo Therapeutics Inc. – Major Products and Services
iCo Therapeutics Inc. – History
iCo Therapeutics Inc. – Company Statement
iCo Therapeutics Inc. – Locations And Subsidiaries
iCo Therapeutics Inc. – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

iCo Therapeutics Inc. – Business Description
iCo Therapeutics Inc. – Corporate Strategy
iCo Therapeutics Inc. – SWOT Analysis
SWOT Analysis – Overview
iCo Therapeutics Inc. – Strengths
iCo Therapeutics Inc. – Weaknesses
iCo Therapeutics Inc. – Opportunities
iCo Therapeutics Inc. – Threats
iCo Therapeutics Inc. – Key Competitors

Section 3 – Company Financial Performance Charts

iCo Therapeutics Inc. – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

iCo Therapeutics Inc., Key Information
iCo Therapeutics Inc., Key Ratios
iCo Therapeutics Inc., Share Data
iCo Therapeutics Inc., Major Products and Services
iCo Therapeutics Inc., History
iCo Therapeutics Inc., Key Employees
iCo Therapeutics Inc., Key Employee Biographies
iCo Therapeutics Inc., Key Operational Heads
iCo Therapeutics Inc., Other Locations
iCo Therapeutics Inc., Subsidiaries
iCo Therapeutics Inc., Key Manufacturing facilities
iCo Therapeutics Inc., Key Competitors
iCo Therapeutics Inc., SWOT Analysis
iCo Therapeutics Inc., Ratios based on current share price
iCo Therapeutics Inc., Annual Ratios
iCo Therapeutics Inc., Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

iCo Therapeutics Inc., Performance Chart
iCo Therapeutics Inc., Ratio Charts

★海外企業調査レポート[iCo Therapeutics Inc. (ICO):企業概要、財務及び戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • University of Minnesota(製薬・医療分野):企業M&A動向
    Summary University of Minnesota (UM) is an educational service provider. The university offers different educational programs in the area of medicine, social sciences, science, and business. It provides under graduate degree, post graduate, masters and research courses. UM’s schools and colleges inc …
  • Apotex, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Apotex, Inc. Mergers and Acquis …
  • Orchid Orthopedic Solutions, LLC:企業のM&A・提携動向(医療機器分野)
    Summary Orchid Orthopedic Solutions, LLC (Orchid Orthopedic) is a medical technology company that offers outsourcing services. The company provides design, machining, casting, implant bone in-growth coatings and regulatory consulting services. It offers services such as product design and developmen …
  • Reliance Insurance Limited (RELIANCINS):企業概要およびSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Reliance Insurance Limited" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictl …
  • Scottish Power Limited:企業のM&A・提携動向(発電分野)
    Summary Scottish Power Limited (Scottish Power), a subsidiary of Iberdrola SA, is an integrated energy company that generates, transmits, and distributes electricity, supplies gas, and offers energy management services. The company generates electricity through coal and gas-fueled, hydro, and wind p …
  • Motorola Solutions, Inc. (MSI):企業の財務及び戦略的SWOT分析
    Motorola Solutions, Inc. (MSI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Genesis Energy, L.P.:企業のM&A・提携・投資分析
    Genesis Energy, L.P. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Genesis Energy, L.P. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Poste Italiane Group:企業の戦略・SWOT・財務分析
    SummaryPoste Italiane Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Fi …
  • AMMB Holdings Berhad (AMBANK):企業概要およびSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "AMMB Holdings Berhad" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly foll …
  • CIVCO Medical Solutions:(医療機器分野)企業M&A及び提携動向
    Summary CIVCO Medical Solutions (CIVCO) is a healthcare service provider. The company operates through its radiation oncology and multi-modality imaging. The company’s radiation oncology designs, manufactures and markets products and accessories for head and neck, lung, breast, abdomen, prostate and …
  • Targa Resources Partners LP:企業のM&A・提携動向(発電分野)
    Summary Targa Resources Partners LP (Targa Resources) is an independent midstream company. The company provides midstream natural gas and natural gas liquids (NGL) services. Targa Resources carries out the gathering, compressing, treating, processing and selling of natural gas, and storing, fraction …
  • GVC Holdings PLC:戦略・SWOT・企業財務分析
    GVC Holdings PLC - Strategy, SWOT and Corporate Finance Report Summary GVC Holdings PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Geisinger Health System-製薬・医療分野:企業M&A・提携分析
    Summary Geisinger Health System (GHS) is an integrated health services organization that provides medical and surgical specialties and sub-specialties, and related health services. It offers a range of medical services for patients suffering from diseases related to cardiology, ENT, gastroenterology …
  • Destiny Pharma Ltd.:製品開発パイプライン動向2015
    Destiny Pharma Ltd. - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘Destiny Pharma Ltd. - Product Pipeline Review - 2015’, provides an overview of the Destiny Pharma Ltd.’s pharmaceutical research and development focus. This report provides comprehensive information on the current …
  • Ganesh Benzoplast Ltd. (500153):企業概要、財務及び戦略的SWOT分析
    Summary Ganesh Benzoplast Ltd. (GBL) is a pharmaceutical and chemical company. The company operates in manufacturing and exporting of drug intermediates, pharmaceutical intermediates, bulk drug intermediates, food preservatives, lubricants additives and API/bulk drug. Its food preservatives include …
  • OpenWay Group:企業の戦略的SWOT分析
    OpenWay Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Falck Renewables S.p.A. (FKR):企業のM&A・提携動向(発電分野)
    Summary Falck Renewables S.p.A. (Falck Renewables), formerly Actelios S.p.A., develops, designs, constructs and manages energy production plants. It operates as a subsidiary of Falck S.p.A. The company produces clean energy from various renewable sources including wind energy, solar energy, biomass …
  • GREENoneTEc Solarindustrie GmbH:企業の戦略的SWOT分析
    GREENoneTEc Solarindustrie GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Bell AG:企業の戦略・SWOT・財務分析
    SummaryBell AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings - Deta …
  • Payzone Plc Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Payzone Plc Limited Mergers and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆